Agilon Health
176 hedge funds and large institutions have $9.91B invested in Agilon Health in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 74 increasing their positions, 38 reducing their positions, and 17 closing their positions.
165% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 17
95% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 38
27% more call options, than puts
Call options by funds: $37.8M | Put options by funds: $29.9M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
19% more funds holding
Funds holding: 148 → 176 (+28)
10% more capital invested
Capital invested by funds: $9.02B → $9.91B (+$891M)
0.06% more ownership
Funds ownership: 4.06% → 4.12% (+0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$128M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$67.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.7M |
| 4 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$57.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CDR
Clayton Dubilier & Rice
New York
|
-$272M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$56.3M |
| 3 |
Morgan Stanley
New York
|
-$48.6M |
| 4 |
Amundi
Paris,
France
|
-$8.19M |
| 5 |
AACP
Advantage Alpha Capital Partners
San Francisco,
California
|
-$7.13M |
AGL Hedge Fund Activity: Q3 2022 in Review
176 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q3 2022, worth a combined $9.91B — up 9.9% from $9.02B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new AGL positions and 17 closed out — a net gain of 28 holders — while 74 added to existing stakes and 38 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $128M. The largest seller was Clayton Dubilier & Rice, cutting an estimated $272M.
- 176 institutional investors held Agilon Health (AGL) as of Q3 2022, up from 148 in Q2 2022.
- Funds reported $9.91B of Agilon Health stock for Q3 2022, up 9.9% quarter-over-quarter.
- 45 funds opened new Agilon Health positions in Q3 2022 and 17 closed out, a net change of +28 holders.
- The largest Agilon Health buyer in Q3 2022 was Capital Research Global Investors, an estimated $128M added.
- The largest Agilon Health seller in Q3 2022 was Clayton Dubilier & Rice, an estimated $272M sold.
Based on aggregated 13F filings for Q3 2022.